Not known Facts About cancer research
Prior to Unituxin™, less than 40% of children with intense neuroblastoma lived five years following analysis. Applied together using a therapy that helps activate the affected person’s immune system, This is actually the first productive immunotherapy for neuroblastoma shown to scale back the potential risk of recurrence and boost survival.Sidn